Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO volumes hitting all-time highs. But recently stock valuations have plummeted,… Read More
The upcoming public offering for Vancouver, Wash.-based biotech company Absci reflects a soaring IPO market and adds to the growing prosperity of Pacific Northwest biotech companies. The company’s success also… Read More
Editor’s note: Sana Biotechnology priced shares on Wednesday evening, raising $587.5 million. See full story here. Sana Biotechnology — the Seattle upstart that’s looking to treat a variety of… Read More
Shares of Seattle Genetics are soaring more than 10% this morning after the Bothell, Wash.-based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a… Read More
Leen Kawas is truly a unicorn. The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the first woman to guide a company to an initial public… Read More
A researcher with ties to Seattle-based biotech company OncoSenX has received a $4.2 million grant from the Canadian Institutes of Health Research for work on a COVID-19 vaccine. John Lewis,… Read More
Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals in the life sciences industry and… Read More
A Seattle startup that took root at the University of Washington has closed a $2.8 million seed round for a drug discovery platform that can sort through millions of protein… Read More
Biomatics Capital, a venture capital firm founded by two Seattle investors with close ties to philanthropists Bill and Melinda Gates, has raised another huge fund to invest in new healthcare… Read More
A-Alpha Bio, a startup aiming to speed up the development of new drugs, announced Tuesday it has won a $225,000 grant from the National Science Foundation (NSF). The funding brings… Read More
Despite some knock-out successes and world-class research, Seattle’s biotechnology industry has remained relatively small compared to other hubs around the country. One of the biggest challenges for the region is… Read More
Accelerator Life Science Partners, a Seattle-based life sciences investment fund and umbrella company, unveiled its newest company with a bang Friday. Proniras Corporation was created to develop the seizure drug tezampanel,… Read More
Stealth-mode startup Taproot Medical Technologies has raised $1.25 million out of a $2.25 million round of funding, according to a filing with the Securities and Exchange Commission. The round is… Read More
Arzeda does work that sounds out of this world — or maybe straight out of science fiction. The company uses fermentation, the same process that gives us beer, to invent completely… Read More
Amid all the hype for recreational marijuana use, it’s easy to forget that cannabis and its related plants are also popular for their medicinal effects. Seattle-based RightSciences is taking full… Read More
Klatu Networks has a very niche market: The company makes IoT technology that keeps millions of medical samples and treatments safe from freezer failures. Klatu, which is co-headquartered in the… Read More
Alzheimer’s remains one of the biggest puzzles in the medical world. It’s a devastating disease that impacts millions of people across the globe, but there are no treatments that can… Read More
When you walk into Juno Therapeutics‘ new headquarters in Seattle, your eyes are immediately drawn to the view. The office’s 12th-floor reception desk offers a stunning panorama of the Olympic mountains,… Read More
Proteins are incredibly important, but incredibly complicated, molecules. They control 98 percent of all biological functions and are used in industries from manufacturing to agriculture. Seattle-based synthetic biology startup Arzeda has… Read More
Genoa Pharmaceuticals — a biopharmaceutical company working on treatments for respiratory diseases — was operating under the radar just last week. But the company sprung into the limelight Monday with a… Read More
We often hear that medical research is approaching “breakthroughs” or is at a “tipping point” in innovation. But what does all that really mean? Dr. Nancy Davidson, a longtime breast… Read More
Seventeen years after founding the Institute for Systems Biology (ISB), spurring the creation of systems biology as a field, genomics and biotechnology pioneer Lee Hood is stepping down as its… Read More
President Donald Trump released his blueprint for the 2018 federal budget on Thursday. It included deep cuts to a number of science-based departments and organizations, including a 20-percent cut to… Read More
In the midst of viral outbreaks like Zika or Ebola, having the right information at the right time can be crucial. One of the best ways to track an outbreak is… Read More
Earth faces some troubling conundrums. On one front, increased levels of carbon dioxide and other gasses are fueling drastic climate change. On another, we’re steadily using up all the planet’s arable… Read More
If you didn’t know snails could be venomous, you’re not alone. But it turns out some are, and a recent study found that one species in particular has a venom… Read More
It’s no secret that wet lab space is hard to come by in Seattle. Small biotech companies often struggle to find appropriate facilities, and retrofitting existing buildings can be incredibly… Read More
Genomics, or the study of a person’s genes, has long been seen as an essential part of understanding human health, and particularly learning about and treating cancer. But less flashy… Read More
For cancer researchers, understanding the intricacies of a cell is essential to treating patients and developing new therapies. Often this understanding is found through painstaking examination of a cell’s surface… Read More
When Dr. Sebastian Mikolajczak joined Seattle’s Center for Infectious Disease Research eleven years ago, he had a job to do: create a vaccine for malaria. Easier said than done. Although malaria… Read More